Regulating Medical Software Platforms

This chapter explores the complexities of regulating software as a medical device, emphasizing the balance between thorough oversight and cost-effective innovation. It highlights the need for robust monitoring systems to ensure continuous validation and integration of AI models in clinical practice, alongside streamlined post-market surveillance strategies.